Carmen Pilar Simeón i Aznar Instituciones de las que forman parte Investigador/a principal Enfermedades Sistémicas Vall Hebron Institut de Recerca Email Carmen Pilar Simeón i Aznar Email Instituciones de las que forman parte Investigador/a principal Enfermedades Sistémicas Vall Hebron Institut de Recerca
Líneas de investigación Specific Antinuclear antibodies of scleroderma as markers for different clinical patterns. We want to establish the relationship between the presence of specific autoantibodies for scleroderma (anti-centromere, anti-topoisomerase 1, anti-polymerase III, anti-U3 RNP, Anti-Th/To, Anti-Pm/Scl, anti-Ku) with the different demographic and clinical features as well as with the disease prognosis. IP: Carmen Pilar Simeón i Aznar, Vicenç Fonollosa Pla Genetic basis of scleroderma. With this study we aim at studying the genetic background of the disease to deepen in its pathogenesis to be able to establish links between genetic variations and different clinic-biologic patterns. This research is based on a multicentric study and it is led by Prof. Javier Martín from the "Instituto López-Neyra" of Parasitology, CSIC (Granada). We contribute to it by sending samples from our cohort of patients along with the clinical data. IP: Carmen Pilar Simeón i Aznar, Vicenç Fonollosa Pla Spanish Registry of Scleroderma patients (Systemic Autoimmune Diseases Group, Spanish Internal Medicine Association). This multicentric study includes 14 hospitals with a cohort of 916 scleroderma patients. Its main goal consists in determining both the prognosis factors and the survival of these patients. IP: Carmen Pilar Simeón i Aznar, Vicenç Fonollosa Pla Significance of Capillaroscopy in Raynaud's phenomenon and scleroderma. We want to describe the capillaroscopy alterations observed in patients with Raynaud's phenomenon and scleroderma. Our main objective is to establish the different patterns that may be related to visceral involvement and to the prognosis in the early stages of the disease. IP: Carmen Pilar Simeón i Aznar, Vicenç Fonollosa Pla Paginación Página actual 1 Página 2 Siguiente página › Última página » Proyectos EUSTAR PROJECT 2023 IP: Carmen Pilar Simeón i Aznar Colaboradores: - Entidad financiadora: European Scleroderma Trials and Research group Financiación: 20000 Referencia: EUSTAR/GRANT/2023/SIMEON Duración: 01/05/2024 Ajuts Grups de Recerca (SGR) 2022 IP: Jaume Alijotas Reig Colaboradores: Moisés Labrador Horrillo, Carmen Pilar Simeón i Aznar, Anna Sala Cunill, Roser Solans Laque, Segundo Bujan Rivas, Mar Guilarte Clavero, Vicenç Fonollosa Pla, Fernando Martínez Valle, Victòria Cardona Dahl, Francesc Miro Mur, Alfredo Guillen Del Castillo, Albert Selva O'Callaghan, José Pardos Gea, Laura Donaire Lancharro, Ariadna Anunciacion Llunell Entidad financiadora: Agència Gestió Ajuts Universitaris i de Recerca Financiación: 0.01 Referencia: 2021 SGR 00048 Duración: 01/01/2022 - 30/06/2025 Estudio de expresión de antígenos en tejido tumoral de pacientes con Esclerosis Sistémica. IP: Alfredo Guillen Del Castillo Colaboradores: Carmen Pilar Simeón i Aznar, Vicenç Fonollosa Pla, Maria Roca Herrera, Janire Perurena Prieto, Irene Sansano Valero Entidad financiadora: Instituto de Salud Carlos III Financiación: 75020 Referencia: PI22/01804 Duración: 01/01/2023 - 31/12/2025 Design of an integrative patients stratification approach for the systemic sclerosis management IP: Carmen Pilar Simeón i Aznar Colaboradores: - Entidad financiadora: Fundació La Marató de TV3 Financiación: 72250 Referencia: 202022-30-31-32-33 Duración: 10/05/2021 - 31/12/2024 Paginación Página actual 1 Página 2 Página 3 Siguiente página › Última página »
